Women's Ischemia Trial to Reduce Events in Non-Obstructive CAD (WARRIOR)

Abstract

The WARRIOR trial is a multicenter, prospective, randomized, blinded outcome evaluation (PROBE design) evaluating intensive medical therapy vs usual care in 4,422 symptomatic women with ischemia but no obstructive CAD. The study aims to determine whether an intensive medication treatment strategy to modify risk factors in women with chest pain and/or abnormal stress tests, but non-obstructed coronary arteries will reduce their likelihood of dying, having a heart attack, stroke or being hospitalized. This project will activate 50-125 recruitment sites from across the US to enroll and follow these women for up to three years to assess adverse outcomes.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2022
Accession Number
AD1191279

Entities

People

  • Carl J Pepine
  • Eileen M Handberg

Organizations

  • University of Florida

Tags

DTIC Thesaurus Topics

  • Active Duty
  • Biomedical Research
  • Cardiovascular Diseases
  • Clinical Trials
  • Computer Programming
  • Covid-19
  • Data Management
  • Department Of Defense
  • Digital Communications
  • Diseases
  • Health Services
  • Heart Diseases
  • Hospitals
  • Institutional Review Board
  • Medical Personnel
  • Military Facilities
  • Myocardial Ischemia
  • Pain
  • Patient Care
  • Risk Factors
  • Therapy
  • Training
  • Vascular Diseases
  • X-Ray Computed Tomography

Fields of Study

  • Medicine

Readers

  • Cardiovascular Physiology
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
  • Oncology